by Clark and DiStefano | Jul 23, 2020 | PRODUCT RECALLS
Several companies have initiated recalls of extended release versions of the first-line type 2 diabetes treatment metformin due to unsafe levels of N-nitrosodimethylamine (NDMA), a probable human carcinogen. On May 28, the Food and Drug Administration (FDA) informed...
